- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SGMO
Recent news which mentions SGMO
From Benzinga
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
From InvestorPlace
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
April 10, 2023
From Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
From InvestorPlace
From Benzinga
UBS Group, Credit Suisse And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 20, 2023
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
From Benzinga
10 Companies That Had Tons of Money in SVB When It Collapsed
March 13, 2023
From InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
February 27, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 27, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
From Benzinga
Sangamo Therapeutics Shares Updated Data From Fabry Gene Therapy Study, Says It Shows Evidence Of Clinical Benefit
February 23, 2023
Tickers
SGMO
From Benzinga
Earnings Scheduled For February 22, 2023
February 22, 2023
From Benzinga
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
February 10, 2023
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 21, 2022
From Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
From Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
From Benzinga
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
September 23, 2022
From Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.